Brazilian Journal of Biological Sciences (ISSN 2358-2731)

Home > Archive > v. 2, n. 3 (2015) > Pelegrina


Vol. 2, No. 3, p. 39-50 - Jun. 30, 2015


Pharmacological effect of one icv dose of allopregnanolone in the female rat: behavioral profile

Laura Tatiana Pelegrina, Carla Escudero, Fernando Alfredo Giuliani, Sebastián Marcelo Manuel García, Ricardo Jorge Cabrera and Myriam Raquel Laconi

We have previously observed that intracerebroventricular allopregnanolone (ALLO) injection produced an anxiolytic effect and inhibited sexual receptivity when the test was performed in a separate manner. Also, ALLO reverts learning deficit in female rats in the hippocampi. To study the behavioral effects of an acute treatment with ALLO in the right lateral ventricle we used two approaches: a- A battery test to analyze the anxiety and mating behavior. And b- The avoidance test and novel object recognition test to evaluate its effect on memory and learning. Ovariectomized rats were injected with estrogen and progesterone. After it ALLO or vehicle were administered into the right lateral ventricle. To reach the objective (a) rats were put in a sequential battery test in the next order: 1-Open field. 2- Plus maze task. 3- Mating behavior. For the aim (b) it was performed a Novel Object Recognition Test and Step-down Inhibitory Avoidance Task. ALLO did not affect locomotors-exploratory behavior. Animals treated with ALLO, spent more time and had more entries into the open arm in a plus maze task and lordosis quotient was lower than in the control group. ALLO increased the latency in step down test and had no effects on discrimination index test in NORT. Here we demonstrated that one pharmacological dose of ALLO in ovariectomized primed rats is enough to generate all changes observed in the battery test. Moreover, the acute treatment with ALLO in lateral ventricle enhanced the memory acquisition in an avoidance task.

Allopregnanolone, Neurosteroids, Behavior, Female rat, Memory.

Full text

Bengtsson, S. K.; Johansson, M.; Backstrom, T.; Nitsch, R. M.; Wang, M. Brief but chronic increase in allopregnanolone cause accelerated AD pathology differently in two mouse models. Curr. Alzheimer Res., v. 10, p. 38-47, 2013.

Bicíková, M.; Hampl, R. Neurosteroids and their function. Cas. Lek. Cesk., v. 146, n. 3, p. 223-226, 2007.

Brinton, R. D. Neurosteroids as regenerative agents in the brain: therapeutic implications. Nat. Rev. Endocrinol., v. 9, p. 241-250, 2013.

Cammarota, M.; Bevilaqua, L. R.; Rossato, J. I.; Lima, R. H.; Medina, J. H.; Izquierdo, I. Parallel memory processing by the CA1 region of the dorsal hippocampus and the basolateral amygdala. Proc. Natl. Acad. Sci. USA, v. 105, p. 10279-10284, 2008.

Casada, J. H.; Amdur, R.; Larsen, R.; Liberzon, I. Psychophysiologic responsivity in posttraumatic stress disorder: generalized hyperresponsiveness versus trauma specificity. Biol. Psychiatry, v. 44, p. 1037-1044, 1998.

Cavigelli, S. A.; McClintock, M. K. Fear of novelty in infant rats predicts adult corticosterone dynamics and an early death. Proceedings of the National Academy of Science, v. 100, p. 16131-16136, 2003.

Concas, A.; Mostallino, M. C.; Perra, C.; Lener, R.; Roscetti, G.; Barbaccia, M. L.; Purdy, R. H.; Biggio, G. Functional correlation between allopregnanolone and [35S]-TBPS binding in the brain of rats exposed to isoniazid, pentylenetetrazol or stress. Br. J. Pharmacol., v. 118, p. 839-46, 1996.

Edinger, K. L.; Frye, C. A. Testosterone's anti-anxiety and analgesic effects may be due in part to actions of its 5 alpha-reduced metabolites in the hippocampus. Psychoneuroendocrinology, v. 30, p. 418-430, 2005.

Endicott, J.; Amsterdam, J.; Eriksson, E.; Frank, E.; Freeman, E.; Hirschfeld, R.; Ling, F.; Parry, B.; Pearlstein, T.; Rosenbaum, J.; Rubinow, D.; Schmidt, P.; Severino, S.; Steiner, M.; Stewart, D. E.; Thys-Jacobs, S. Is premenstrual dysphoric disorder a distinct clinical entity? J. Womens Health Gend. Based Med., v. 8, p. 663-679, 1999.

Ennaceur, A.; Delacour, J. A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav. Brain Res., v. 31, p. 47-59, 1988.

Erskine, M. S.; MacLusky, N. J.; Baum, M. J. Effect of 5 alpha-dihydrotestosterone on sexual receptivity and neural progestin receptors in ovariectomized rats given pulsed estradiol. Biol. Reprod., v. 33, p. 551-559, 1985.

Escudero, C.; Casas, S.; Giuliani, F.; Bazzocchini, V.; García, S. Yunes, R.; Cabrera, R. Allopregnanolone prevents memory impairment: effect on mRNA expression and enzymatic activity of hippocampal 3-α hydroxysteroid oxide-reductase. Brain Res. Bull., v. 87, p. 280-285, 2012.

Evans, J.; Sun, Y.; McGregor, A., Connor, B. Allopregnanolone regulates neurogenesis and depressive/anxiety-like behaviour in a social isolation rodent model of chronic stress. Neuropharmacology, v. 63, p. 1315-1326, 2012.

File, S. E. New strategies in the search for anxiolytics. Drug Des. Deliv., v. 5, p. 195-201, 1990.

Freeman, E. W.; Purdy, R. H.; Coutifaris, C.; Rickels, K.; Paul, S. M. Anxiolytic metabolites of progesterone: correlation with mood and performance measures following oral progesterone administration to healthy female volunteers. Neuroendocrinology, v. 58, p. 478-484, 1993.

Frye, C. A.; Bayon, L. E. Mating stimuli influence endogenous variations in the neurosteroids 3 alpha, 5 alpha-THP and 3 alpha-Diol. J. Neuroendocrinol., v. 11, p. 839-847, 1999.

Frye C. A.; Erskine, M. S. Influence of time of mating and paced copulation on induction of pseudopregnancy in cyclic female rats. J. Reprod. Fertil., v. 90, p. 375-385, 1990.

Frye, C. A.; Koonce, C. J.; Walf, A. A. Novel receptor targets for production and action of allopregnanolone in the central nervous system: a focus on pregnane xenobiotic receptor. Front Cell. Neurosci., v. 8, p. 106, 2014.

Frye, C. A.; Paris, J. J.; Rhodes, M. E. Engaging in paced mating, but neither exploratory, anti-anxiety, nor social behavior, increases 5 alpha-reduced progestin concentrations in midbrain, hippocampus, striatum, and cortex. Reproduction, v. 133, p. 663-674, 2007.

Frye, C. A.; Petralia, S. M.; Rhodes, M. E. Estrous cycle and sex differences in performance on anxiety tasks coincide with increases in hippocampal progesterone and 3 alpha, 5 alpha-THP. Pharmacol. Biochem. Behav., v. 67, p. 587-596, 2000.

Frye, C. A.; Paris, J. J.; Walf, A. A.; Rusconi, J. C. Effects and mechanisms of 3α, 5α,-THP on emotion, motivation, and reward functions involving pregnane xenobiotic receptor. Front. Neurosci., v. 5, 18 p., 2010. Available from: <>. Accessed in: Apr. 2, 2015.

Gracia, C. R.; Freeman, E. W.; Sammel, M. D.; Lin, H.; Sheng, L.; Frye, C. Allopregnanolone levels before and after selective serotonin reuptake inhibitor treatment of premenstrual symptoms. J. Clin. Psychopharmacol., v. 29, p. 403-405, 2009.

Johansson, I.; Birzniece, V.; Lindblad, C.; Olsson, T.; Backstrom, T. Allopregnanolone inhibits learning in the Morris watermaze. Brain Res., v. 934, p. 25-131, 2002.

Kokate, T. G.; Juhng, K. N.; Kirkby, R. D.; Llamas, J.; Yamaguchi, S.; Rogawski, M. A. Convulsant actions of the neurosteroid pregnenolone sulfate in mice. Brain Res., v. 831, p. 119-124, 1999.

Laconi, M. R.; Cabrera, R. J. Effect of centrally injected allopregnanolone on sexual receptivity, luteinizing hormone release, hypothalamic dopamine turnover, and release in female rats. Endocrine, v. 7, p. 77-83, 2002.

Laconi, M. R.; Casteller, G.; Gargiulo, P. A.; Bregonzio, C.; Cabrera, R. J. The anxiolytic effect of allopregnanolone is associated with gonadal hormonal status in female rats. Eur. J. Pharmacol., v. 417, p. 111-116, 2001.

Laconi, M. R.; Reggiani, P. C.; Penissi, A.; Yunes, R.; Cabrera, R. J. Allopregnanolone modulates striatal dopamingergic activity of rats under different gonadal hormones conditions. Neurol. Res., v. 29, p. 622-627, 2007.

Laconi, M. R.; Chavez, C.; Cavicchia, J. C.; Fóscolo, M.; Sosa, Z.; Yunes, R. F.; Cabrera, R. J. Allopregnanolone alters the luteinizing hormone, prolactin, and progesterone serum levels interfering with the regression and apoptosis in rat corpus luteum. Horm. Metab. Res., v. 44, p. 632-638, 2012.

Majewska, M. D. Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog. Neurobiol., v. 38, p. 379-395, 1992.

Mayo, W.; Le Moal, M.; Abrous, D. Pregnenolone sulfate and aging of cognitive functions: behavioral, neurochemical, and morphological investigations. Horm. Behav., v. 40, n. 2, p. 215-217, 2001.

McEwen, B. Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol. Sci., v. 12, p. 141-147, 1991.

Mellon, S. H. Neurosteroids: biochemistry, modes of action, and clinical relevance. J. Clin. Endocrinol. Metab., v. 78, p. 1003-1008, 1994.

Mòdol, L.; Darbra, S.; Pallarès, M. Neurosteroids infusion into the CA1 hippocampal region on exploration, anxiety-like behaviour and aversive learning. Behav. Brain Res., v. 222, p. 223-229, 2011.

Nanfaro, F.; Cabrera, R.; Bazzocchini, V.; Laconi, M.; Yunes, R. Pregnenolone sulfate infused in lateral septum of male rats impairs novel object recognition memory. Pharmacol. Rep., v. 62, p. 265-272, 2010.

National Research Council. Guide for the care and use of laboratory animals. 8. ed. Washington, D. C.: The National Academies Press, 2011. Available from: <>. Acessed in: Apr. 2, 2015.

Paul, S. M.; Purdy, R. H. Neuroactive steroids. FASEB J., v. 6, p. 2311-2322, 1992.

Paxinos, G.; Watson, C. The rat brain in stereotaxic coordinates. New York: Academic Press, 1997.

Prickaerts, J.; van Staveren, W.; Sik, A.; Markerink-van Ittersum, M.; Niewohner, U.; van der Staay, F.; Blokland, A.; de Vente, J. Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat. Neuroscience, v. 113, p. 251-361, 2002.

Purdy, R. H.; Morrow, A. L.; Moore, P. H.; Paul, S. M. Stress-induced elevations of γ-aminobutiric acid type A receptor-active steroids in the rat brain. Neurobiology, v. 10, p. 4553-4557, 1991.

Robel, P.; Baulieu, E. E. Neurosteroids biosynthesis and function. Trends Endocrinol. Metab., v. 5, p. 1-8, 1994.

Romeo, E.; Ströhle, A.; Spalletta, G.; di Michele, F.; Hermann, B.; Holsboer, F.; Pasini, A.; Rupprecht, R. Effects of antidepressant treatment on neuroactive steroids in major depression. Am. J. Psychiatry, v. 155, p. 910-913, 1998.

Sandstrom, N. J.; Williams, C. L. Memory retention is modulated by acute estradiol and progesterone replacement. Behav. Neurosci., v. 115, p. 384-393, 2001.

Santoru, F.; Berretti, R.; Locci, A.; Porcu, P.; Concas, A. Decreased allopregnanolone induced by hormonal contraceptives is associated with a reduction in social behavior and sexual motivation in female rats. Psychopharmacology, v. 231, p. 3351-3364, 2014.

Sato, T.; Tanaka, K.; Ohnishi, Y.; Teramoto, T.; Irifune, M.; Nishikawa, T. Effects of estradiol and progesterone on radial maze performance in middle-aged female rats fed a low-calcium diet. Behav. Brain Res., v. 150, p. 33-42, 2004.

Uzunova, V.; Sheline, Y.; Davis, J. M.; Rasmusson, A.; Uzunov, D. P.; Costa, E.; Guidotti, A. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc. Natl. Acad. Sci. USA, v. 95, p. 3239-3244, 1998.

Wang, M. Neurosteroids and brain aging. Minerva Ginecol., v. 65, p. 587-605, 2013.

Zou, L. B.; Yamada, K.; Sasa, M.; Nakata, Y.; Nabeshima, T. Effects of sigma(1) receptor agonist SA4503 and neuroactive steroids on performance in a radial arm maze task in rats. Neuropharmacology, v. 39, p. 1617-1627, 2000.